Back to Search
JEREMY JOYAL, M.D.
M.D.
Pain Medicine (Anesthesiology) Physician
NPI: 1861622219IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pain Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Pain Medicine
Code: 207LP2900X
8658373-1205(UT)
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 2009
Research & Publications (20)
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
PMID 19641130·Am J Physiol Regul Integr Comp Physiol·2009
7-preclinical
Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).
PMID 19572702·Bioconjug Chem·2009
7-preclinical
[Supply and demand: the influence of energy metabolism on angiogenesis].
PMID 19409184·Med Sci (Paris)·2009
7-preclinical
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.
PMID 19111054·J Med Chem·2009
8-other
A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents.
PMID 18997942·Chem Commun (Camb)·2008
8-other
Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor.
PMID 18929155·Semin Perinatol·2008
7-preclinical
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis.
PMID 18836459·Nat Med·2008
7-preclinical
Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression.
PMID 18483087·J Nucl Med·2008
7-preclinical
Development of a novel noncompetitive antagonist of IL-1 receptor.
PMID 18453620·J Immunol·2008
7-preclinical
Lysophosphatidic acid induces endothelial cell death by modulating the redox environment.
PMID 17122328·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-alpha and consecutively Tie2 dependent.
PMID 16439712·Arterioscler Thromb Vasc Biol·2006
7-preclinical
Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
PMID 15869604·J Thromb Haemost·2005
8-other
Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain.
PMID 15284079·Am J Physiol Regul Integr Comp Physiol·2004
7-preclinical
Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity.
PMID 12626359·Am J Physiol Regul Integr Comp Physiol·2003
7-preclinical
Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor.
PMID 12444157·J Immunol·2002
7-preclinical
Stimulation of enveloped virus infection by beta-amyloid fibrils.
PMID 12119288·J Biol Chem·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 96 E KIMBALLS LN STE 408
DRAPER, UT 84020 - Phone
- (801) 572-1186
Quick Facts
- NPI
- 1861622219
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile